Skip to main content

Rising prevalence of colorectal cancer and other endoscopy-related diseases to boost the growth of endoscope reprocessing device market.

 


Market Overview:

Endoscope reprocessing devices are those which are made to kill the organisms in the reusable endoscopes using high disinfectants or liquid chemical solutions to expose the exterior surfaces and the interior channels. Manual cleaning, sterilization, documentation, leak testing and pre –cleaning are some of the steps performed in endoscopy reprocessing.

Competitive Landscape:

The major players operating the endoscope reprocessing device market are STERIS Plc., Cilag GmbH International, Steelco S.p.A., Minntech Corp PENTAX Medical, Medivators Inc., Wassenburg Medical B.V., Soluscope, ENDO-TECHNIK W.Griesat GmbH, Johnson & Johnson and Getinge AB. 

Key Market Drivers:

Rising prevalence of colorectal cancer and other endoscopy-related diseases are anticipated to augment the growth of the global endoscope reprocessing device market. For instance, as per the American Cancer Society, nearly 97,220 people are diagnosed with colorectal cancer and 43,030 rectal cancer by the end of 2018.

Furthermore, increasing cardiovascular diseases which are treated with using ERs is anticipated to boost the growth of the global endoscope reprocessing device market. For instance, as per OECD, 45,307 people have undergone the coronary heart bypass surgery/operation in Germany as of 2018. 

Covid-19 Impact Analysis:

During the pandemic, along with the sterilization the ERs have also increased as the reprocessors have been a crucial part for the endoscopy surgeries which led to the growth of the global endoscope reprocessing device market.

Key Takeaways:

The global endoscope reprocessing device market is expected to exhibit a CAGR of XX % during the forecast period due to frequent approvals, quick launches of products. For instance, in April 2019, Advanced Sterilization Products gained US. FDA, launched for the ASP AEROFLEX automated endoscopes reprocessors.

Among Regions North America, Asia Pacific and Europe are anticipated to witness robust growth in the global endoscope reprocessing device market due to increasing prevalence of diseases, frequent approvals. As per the Globocan, 3,244 people suffer from stomach cancer in Canada and 5,139 people suffer from pancreatic cancer.

 

 

Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Analysis

  A primary driver for this market is the worldwide increase in occurrence of diabetes and cancer, across all age groups. According to the World Health Organization (WHO) 2018 statistics, the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. Moreover according to the World Health Organization cancer factsheet 2018, Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018.  Furthermore, increasing old age population is another driver, which is anticipated to create a high growth scenario for the market. As per the World Population Prospects 2019 revision, the number of people aged 80 years or over is projected to be triple, from 143 million in 2019 to 426 million in 2050. Alternatively, factors restraining the market are complications and risks associated with the treatment including diarrhea, nausea, hair loss, vomiting, severe infections, infertility, and heart complications....
Post a Comment
Read more

North America is expected to lead the global cosmetology market due to growing number of minimally invasive surgeries in the region

  Market Overview: Cosmetology is the field of a beauty practice that includes a variety of practices aimed at making individual’s look and feel their best. Competitive Landscape: GC Aesthetics, Mentor Worldwide LLC, Sientra Inc., Zimmer Holdings Inc., 3M Health Care, Allergan, Inc., Implantech Associates Inc., Institut Straumann AG, Nobel Biocare Holding AG, and Spectrum Designs Medical.   Key Market Drivers: An increasing number of cosmetic surgeries is expected to expand the global cosmetology market size. For instance, according to American Society of Plastic Surgeons (ASPS) 2017 reports, around 17.5 million cosmetic surgeries were performed in 2017, U.S. among which breast augmentation, liposuction, and nose reshaping were the top three procedures. High preferences for Botox surgeries which are used to reduce wrinkles and maintain youthful skin is again fostering the growth of the market growth. According to the same source, around 65% of women prefer Botul...
Post a Comment
Read more

Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

  Surgical hemostat is a surgical tool used in many surgical procedures to control bleeding. Surgical hemostats covered in this report include thrombin-based, combination hemostats, oxidized regenerated cellulose-based, gelatin-based, and collagen-based. Internal tissue sealants are typically used in surgeries to bind or hold internal tissues such as blood vessels, internal organs, bone cartilage, dura matter and others. The global surgical hemostats, internal tissue sealants and adhesion barriers market is estimated to account for US$ 4,231.4 Mn in terms of value in 2020 and is expected to reach US$ 7,346.7 Mn by the end of 2027 Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Drivers Increasing number of surgical procedures is expected to propel growth of the global surgical  hemostats , internal tissue sealants and adhesion barriers market over the forecast period. For instance, according to ‘Surgical operations and procedures sta...
Post a Comment
Read more